Gregory S. Day

Neurology
4500 San Pablo Rd S
Jacksonville, FL 32224

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 283 publications

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.

Journal: Neurology
Published: August 26, 2026

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Eligibility for Anti-Amyloid Therapies in Patients With Biomarker-Confirmed Atypical Alzheimer Disease Phenotypes.

Journal: Neurology
Published: August 05, 2026

Author Response: The Neurologist's Role in Promoting Brain Health: Emerging Issues in Neurology.

Author Response: The Neurologist's Role in Promoting Brain Health: Emerging Issues in Neurology.

Journal: Neurology
Published: August 04, 2026

Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review.

Prion disease mimicking rapidly progressive Alzheimer disease: case series and systematic review.

Journal: Journal of neurology
Published: July 31, 2026

Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer's disease using NULISA technology.

Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer's disease using NULISA technology.

Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026

TDP-43 subtypes shape transcriptomic signatures in Alzheimer's disease.

TDP-43 subtypes shape transcriptomic signatures in Alzheimer's disease.

Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026

Diminishing Returns of Novel Autoantibody Discovery in Encephalitis.

Diminishing Returns of Novel Autoantibody Discovery in Encephalitis.

Journal: JAMA neurology
Published: June 29, 2026

Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio.

Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio.

Journal: JAMA neurology
Published: June 01, 2026

Regional cerebral FDG-PET metabolic patterns across severity of extracranial internal carotid artery stenosis.

Regional cerebral FDG-PET metabolic patterns across severity of extracranial internal carotid artery stenosis.

Journal: Neuroimage. Reports
Published: May 26, 2026

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Autoimmune Encephalitis as Treatment-Responsive Cause of Rapidly Progressive Dementia: A Multicenter Prospective Cohort Study.

Journal: Neurology
Published: May 15, 2026

Optimized plasma p-tau217 and p-tau217/Aβ42 cutoffs enhance detection of pre-clinical Alzheimer's disease across diverse participants.

Optimized plasma p-tau217 and p-tau217/Aβ42 cutoffs enhance detection of pre-clinical Alzheimer's disease across diverse participants.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: May 04, 2026

Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus.

Acute Brain Injury in New-Onset Refractory Status Epilepticus and Etiology-Defined Status Epilepticus.

Journal: JAMA neurology
Published: April 27, 2026
Showing 1-12 of 283

Last Updated: 09/26/2026